Patents Assigned to Meditor Pharmaceuticals Ltd.
  • Pharmaceutical compositions for headache, migraine, nausea and emesis
    Patent number: 8673979
    Abstract: S-alkylsiothiouronium derivatives such as S-ethylisothiouronium diethylphosphate are used for the treatment of headaches, in particular, migraines, as well as for the prevention or treatment of nausea and vomiting. The compositions of the invention are also effective in preventing or alleviating emesis associated with migraines or other medical conditions such as chemotherapy or radiotherapy, as well as other symptoms of migraines including phonophobia and photophobia.
    Type: Grant
    Filed: October 18, 2006
    Date of Patent: March 18, 2014
    Assignee: Meditor Pharmaceuticals Ltd.
    Inventors: Raphael Barkan, Alexander Mirimsky
  • S-ALKYLISOTHIOURONIUM DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES
    Publication number: 20090186854
    Abstract: The present invention relates to uses of S-alkylisothiouronium derivatives for treating inflammation. In particular, the present invention provides extended release pharmaceutical dosage forms of S-alkylisothiouronium derivatives and methods of use thereof for the treatment of various inflammatory diseases or conditions.
    Type: Application
    Filed: March 25, 2007
    Publication date: July 23, 2009
    Applicant: Meditor Pharmaceuticals Ltd.
    Inventors: Refael Barkan, Victor Ghicavii
  • PHARMACEUTICAL COMPOSITIONS FOR HEADACHE, MIGRAINE, NAUSEA AND EMESIS
    Publication number: 20070088005
    Abstract: S-alkylsiothiouronium derivatives such as S-ethylisothiouronium diethylphosphate are used for the treatment of headaches, in particular, migraines, as well as for the prevention or treatment of nausea and vomiting. The compositions of the invention are also effective in preventing or alleviating emesis associated with migraines or other medical conditions such as chemotherapy or radiotherapy, as well as other symptoms of migraines including phonophobia and photophobia.
    Type: Application
    Filed: October 18, 2006
    Publication date: April 19, 2007
    Applicant: Meditor Pharmaceuticals Ltd.
    Inventors: Raphael Barkan, Alexander Mirimsky
  • Pharmaceutical compositions for headache, migraine, nausea and emesis
    Patent number: 7148208
    Abstract: S-alkylsiothiouronium derivatives such as S-ethylisothiouronium diethylphosphate are used for the treatment of headaches, in particular, migraines, as well as for the prevention or treatment of nausea and vomiting. The compositions of the invention are also effective in preventing or alleviating emesis associated with migraines or other medical conditions such as chemotherapy or radiotherapy, as well as other symptoms of migraines including phonophobia and photophobia.
    Type: Grant
    Filed: March 5, 2003
    Date of Patent: December 12, 2006
    Assignee: Meditor Pharmaceuticals Ltd.
    Inventors: Raphael Barkan, Alexander Mirimsky
  • Pharmaceutical compositions for headache, migraine, nausea and emesis
    Publication number: 20040006044
    Abstract: S-alkylsiothiouronium derivatives such as S-ethylisothiouronium diethylphosphate are used for the treatment of headaches, in particular, migraines, as well as for the prevention or treatment of nausea and vomiting. The compositions of the invention are also effective in preventing or alleviating emesis associated with migraines or other medical conditions such as chemotherapy or radiotherapy, as well as other symptoms of migraines including phonophobia and photophobia.
    Type: Application
    Filed: March 5, 2003
    Publication date: January 8, 2004
    Applicant: MEDITOR PHARMACEUTICALS LTD.
    Inventors: Raphael Barkan, Alexander Mirimsky
  • Pharmaceutical compositions comprising S-alkylisothiouronium derivatives
    Patent number: 6160008
    Abstract: S-Alkylisothiouronium salts with phosphorus-containing acids are described. The compounds are used in processes of treating acute hypotension, which may result, for example, from shock or hemorrhage, and in processes for treating hyperoxic conditions, for example, oxygen poisoning.
    Type: Grant
    Filed: June 9, 1999
    Date of Patent: December 12, 2000
    Assignee: Meditor Pharmaceuticals Ltd.
    Inventors: Lev Mizrakh, Valentin Znamensky, Evgeni Arzamastsev, Lev Shagalov, Valeri Kovtun, Vladimir Jashounsky, Marina Kochetkova, Galina Bondareva, Olga Terekhova, Victor Gikavy, Victor Darchuk